Xiaoting Hu

Array ( [id] => 7088532 [patent_doc_number] => 20050008644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Potentiation of the immune response' [patent_app_type] => utility [patent_app_number] => 10/778667 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3336 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008644.pdf [firstpage_image] =>[orig_patent_app_number] => 10778667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7446978 [patent_doc_number] => 20040186066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Method of treatment with nelfinavir' [patent_app_type] => new [patent_app_number] => 10/776568 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11753 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186066.pdf [firstpage_image] =>[orig_patent_app_number] => 10776568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807663 [patent_doc_number] => 20060094017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Immunogens for hiv vaccine' [patent_app_type] => utility [patent_app_number] => 10/544499 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7663 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094017.pdf [firstpage_image] =>[orig_patent_app_number] => 10544499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 922954 [patent_doc_number] => 07318926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Glycosylated specificity exchangers' [patent_app_type] => utility [patent_app_number] => 10/773628 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18745 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/318/07318926.pdf [firstpage_image] =>[orig_patent_app_number] => 10773628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677644 [patent_doc_number] => 20040152182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Viral particles released after infection by human cytomegalovirus, and their use as vaccine' [patent_app_type] => new [patent_app_number] => 10/770467 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8018 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152182.pdf [firstpage_image] =>[orig_patent_app_number] => 10770467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7316726 [patent_doc_number] => 20040223977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Fusion peptide HIV vaccines' [patent_app_type] => new [patent_app_number] => 10/769991 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7218 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20040223977.pdf [firstpage_image] =>[orig_patent_app_number] => 10769991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423225 [patent_doc_number] => 20040265320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein' [patent_app_type] => new [patent_app_number] => 10/766528 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19222 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265320.pdf [firstpage_image] =>[orig_patent_app_number] => 10766528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7599707 [patent_doc_number] => 07582740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Methods and kits for detecting SARS-associated coronavirus' [patent_app_type] => utility [patent_app_number] => 10/764075 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 6 [patent_no_of_words] => 8854 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582740.pdf [firstpage_image] =>[orig_patent_app_number] => 10764075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303207 [patent_doc_number] => 20040115184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Methods and compositions for modifying apolipoprotein b mrna editing' [patent_app_type] => new [patent_app_number] => 10/468987 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20992 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115184.pdf [firstpage_image] =>[orig_patent_app_number] => 10468987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468023 [patent_doc_number] => 20040198960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae' [patent_app_type] => new [patent_app_number] => 10/483447 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10060 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198960.pdf [firstpage_image] =>[orig_patent_app_number] => 10483447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925799 [patent_doc_number] => 20050239054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Method and compositions for identifying anti-HIV therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 10/740694 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 401863 [patent_no_of_claims] => 180 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10740694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776348 [patent_doc_number] => 20060104988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Vaccines against hiv-1 tat protein to generate neutralizing antibodies' [patent_app_type] => utility [patent_app_number] => 10/539677 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17446 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104988.pdf [firstpage_image] =>[orig_patent_app_number] => 10539677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7318824 [patent_doc_number] => 20040224883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Compositions and methods for treating HIV infections' [patent_app_type] => new [patent_app_number] => 10/737288 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19631 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224883.pdf [firstpage_image] =>[orig_patent_app_number] => 10737288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436129 [patent_doc_number] => 20040185057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Therapeutical vaccination' [patent_app_type] => new [patent_app_number] => 10/480534 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 31035 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185057.pdf [firstpage_image] =>[orig_patent_app_number] => 10480534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256203 [patent_doc_number] => 20040259827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Compositions and methods for the abrogation of cellular proliferation utilizing the human immunodeficiency virus Vpr protein' [patent_app_type] => new [patent_app_number] => 10/734024 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19848 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259827.pdf [firstpage_image] =>[orig_patent_app_number] => 10734024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 376931 [patent_doc_number] => 07312031 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-12-25 [patent_title] => 'Alpha-complementation viral fusion assay' [patent_app_type] => utility [patent_app_number] => 10/729069 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11267 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312031.pdf [firstpage_image] =>[orig_patent_app_number] => 10729069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7323470 [patent_doc_number] => 20040137436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Method for measuring drug resistance' [patent_app_type] => new [patent_app_number] => 10/258150 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17040 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137436.pdf [firstpage_image] =>[orig_patent_app_number] => 10258150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4572345 [patent_doc_number] => 07824851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => '2′-branched nucleosides and Flaviviridae mutation' [patent_app_type] => utility [patent_app_number] => 10/715729 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 44876 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824851.pdf [firstpage_image] =>[orig_patent_app_number] => 10715729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649716 [patent_doc_number] => 20060135451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 10/534774 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13856 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135451.pdf [firstpage_image] =>[orig_patent_app_number] => 10534774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5069421 [patent_doc_number] => 20070190523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Method and compositions for identifying anti-hiv therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 10/554287 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 195041 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190523.pdf [firstpage_image] =>[orig_patent_app_number] => 10554287 [rel_patent_id] =>[rel_patent_doc_number] =>)